27/08/2026
How satisfied are your patients with the quality of their skin after treatment?
✅ 92.5% of patients(1) are satisfied with the improvement in skin hydration, softness and texture following the use of NCTF® 135 HA.
(1) Clinical trial of 3 sessions of NCTF® 135 HA on healthy volunteers, 2019. Randomized controlled, multicenter (10 centres) and prospective study. 147 subjects included. 3 sessions spaced 21 days apart on the face, neck & décolleté. Clinical scoring + instrumental measurements (H**E2 Study).
Internal reference: NCTF-072-05-2026
NCTF® 135 HA is an injectable anti-ageing product indicated for the filling of superficial wrinkles, for the intense revitalisation and hydration of tired or dull skin, and to improve skin evenness and radiance. It also promotes increased skin density, thickness and elasticity in mature or sagging skin.
Class III injectable medical device (CE 0477).
Adverse effects of NCTF® 135 HA: Systemic allergic reactions (angioedema, allergic reaction, itching, skin rash, chills, fever), local inflammatory reactions (erythema, swelling, burning sensation, nodule, granuloma, pain, skin inflammation), local allergic reactions (pruritus) and infection (abscess, herpes).
These medical devices are regulated healthcare products bearing the CE mark in accordance with applicable regulations.
Treatment with dermal filler products may require several touch-ups over time to achieve the desired correction. Use of these products requires administration by a healthcare professional. Please consult your doctor for advice.
Pharmacovigilance contact (to report an adverse event): [email protected]